Legislative Update Board of Scientific Advisors M.K. Holohan, J.D. NCI Office of Government and Congressional Relations 240-781-3410

March 25, 2019 ▪116th Congress

▪FY19 Recap

▪FY20 Appropriations Process

▪Looking Ahead 116th Congress

House 235 Democrats 197 Republicans 3 Vacancies

Senate 53 Republicans 45 Democrats 2 Independents

3 House Leadership in the 116th Congress

Leadership Position Member Speaker of the House (D-CA) House Majority Leader (D-MD) House Majority James Clyburn (D-SC) House Minority Leader Kevin McCarthy (R-CA) House Minority Whip (R-LA)

Committee Chair Ranking Member

House Appropriations Nita Lowey (D-NY) (R-TX) House Appropriations Labor- Rosa DeLauro (D-CT) (R-OK) HHS Subcommittee House Energy & Commerce (D-NJ) (R-OR) House Energy & Commerce Anna Eshoo (D-CA) Michael Burgess (R-TX) Health Subcommittee Majority

Nita Lowey (NY) Rosa DeLauro (CT) Lucille Roybal-Allard Chair, Full Committee Chair, L-HHS Subcommittee (CA) (CA) (WI)

Katherine Clark (FL) (IL) Bonnie Watson (MA) New to Approps and L-HHS New to Approps and L-HHS Coleman (NJ) New to Approps and L-HHS Minority

Kay Granger (TX) Tom Cole (OK) Mike Steve Chuck Ranking Member, Full Ranking Member, L-HHS Simpson Womack Fleischmann Committee Subcommittee (ID) (AR) (TN)

Andy Martha Jaime Herrera- John Tom Graves (GA) Harris Roby Beutler Moolenaar New to L-HHS (MD) (AL) (WA) (MI) Majority

Richard Shelby Roy Blunt (MO) Lamar Lindsey Jerry Moran Chair, L-HHS Subcommittee (AL) Alexander Graham (KS) Chair, Full Committee (TN) (SC)

Shelley Moore James John Marco Cindy Hyde- Capito Lankford Kennedy Rubio Smith (WV) (OK) (LA) (FL) (MS) Minority

Patrick Patty Dick Jack Reed(RI) Jeanne Shaheen Leahy (VT) Murray (WA) Durbin(IL) (NH) Vice Chair, Full Committee Ranking Member, L-HHS Subcommittee

Jeff Merkley Brian Schatz Tammy Baldwin Chris Murphy Joe Manchin (OR) (HI) (WI) (CT) (WV) 116th Congress - Leadership of NIH Authorizing Committees

House Energy & Commerce Senate Health, Education, Committee & Health Subcommittee Labor & Pensions Committee

Frank Pallone (D-NJ) Greg Walden (R-OR) Lamar Alexander (R-TN) Chair, Full Committee Ranking Member, Full Committee Chair

Anna Eshoo (D-CA) Michael Burgess (R-TX) Patty Murray (D-WA) Chair, Health Subcommittee Ranking Member, Health Ranking Member Subcommittee Labor-HHS FY19 Appropriation Enacted before October 1 – first time in 22 years

• Labor-H & Defense bills coupled

• $2B increase for NIH

• $74M increase for NCI

• $400M for Cancer Moonshot (Year 3 of 7)

10 Cancer Moonshot Funding Authorized st Under the 21 Century Cures Act (dollars in millions)

450 400 400 350 300 300 300 250 195 195 194 216 200 150 100 50 0 0 FY 2017FY 2018FY 2019FY 2020FY 2021FY 2022FY 2023FY 2024 FY20 President’s Budget Request

▪ -14.6% for NCI ▪ +$50M Pediatric Initiative

12 NCI Appropriations FY 2015 - 2020 (dollars in millions)

21st Century Cures Act funding shown in orange.

$5,965 $6,144 $5,689 $400 $6,000 $300 $300 $5,247 $5,665 $5,744 $195 $5,000 $5,215 $5,389 $4,950 $5,052 $4,000

$3,000

$2,000

$1,000

$0 FY 2015 FY 2016 FY 2017 FY 2018 FY 2019 FY 2020 PB

Source: NCI Office of Budget and Finance 13 NCI/NIH BUDGET PROCESS FOR REGULAR APPROPRIATION

STEP 1 STEP 2 STEP 3 STEP 4

President signs Congress the appropriations Congressional reconciles & bill into law appropriations finalizes making funds White House OMB committees appropriations available for coordinates with consider legislation & sends NIH & NCI federal agencies President’s to the President to formulate the proposal & President’s budget prepare legislation proposal

FY2020 Return of Budget Caps & the Debt Ceiling in FY20 ▪ March 2019 – Debt ceiling reinstated ▪ October 2019 – Return of budget caps (defense and non- defense) ▪ We have been here before

15 Childhood Cancer STAR (Survivorship, Treatment, Access, Research) Act

• Signed into law in June 2018 • Includes provisions encouraging action from HHS, NCI, and CDC • Required reporting

16 Includes three sections directed toward NIH/NCI (Secs. 101, 111/112, and 202)

• focus on new and continuing investments into childhood, adolescent, and young adult cancer survivorship research (Sec. 202) , as well as biospecimen collection and resources (Sec. 101)

• provisions relating to ped-onc representation (Sec. 111/112) and childhood cancer reporting

17 Legislative Implementation STAR (Survivorship, Treatment, Access, Research) Act

New Activities Underway as of March 2019 include:

▪ RFA, Improving Outcomes for Pediatric, Adolescent and Young Adult Cancer Survivors, posted last month, and aligns directly with the STAR Act. Receipt dates are March 15, 2019 and January 3, 2020.

▪ NCI is planning a meeting in May 2019 to discuss scientific challenges related to pediatric biospecimen collection. The meeting will include pediatric cancer researchers, biospecimen science experts, research organizations and advocates, and will inform implementation opportunities for the STAR Act’s biospecimen and biorepository provisions.

18 Questions? [email protected] 240-781-3410

19